University of Pennsylvania, Philadelphia, PA, United States of America; Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States of America.
University of Pennsylvania, Philadelphia, PA, United States of America; Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States of America; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, United States of America.
Contemp Clin Trials. 2020 Mar;90:105951. doi: 10.1016/j.cct.2020.105951. Epub 2020 Jan 23.
Patients with cancer often receive care that is not aligned with their personal values and goals. Serious illness conversations (SICs) between clinicians and patients can help increase a patient's understanding of their prognosis, goals and values.
In this study, we describe the design of a stepped-wedge cluster randomized trial to evaluate the impact of an intervention that employs machine learning-based prognostic algorithms and behavioral nudges to prompt oncologists to have SICs with patients at high risk of short-term mortality. Data are collected on documented SICs, documented advance care planning discussions, and end-of-life care utilization (emergency room and inpatient admissions, chemotherapy and hospice utilization) for patients of all enrolled clinicians.
This trial represents a novel application of machine-generated mortality predictions combined with behavioral nudges in the routine care of outpatients with cancer. Findings from the trial may inform strategies to encourage early serious illness conversations and the application of mortality risk predictions in clinical settings.
Clinicaltrials.gov Identifier: NCT03984773.
癌症患者经常接受不符合其个人价值观和目标的治疗。临床医生与患者之间的严重疾病对话(SICs)可以帮助患者更好地了解自己的预后、目标和价值观。
本研究描述了一项阶梯式楔形集群随机试验的设计,以评估一种干预措施的影响,该干预措施采用基于机器学习的预测算法和行为提示,促使肿瘤科医生与短期死亡率高的患者进行 SICs。为所有参与的临床医生的患者收集记录的 SICs、记录的预先护理计划讨论以及临终关怀利用(急诊和住院入院、化疗和临终关怀利用)的数据。
这项试验代表了将机器生成的死亡率预测与行为提示在癌症门诊患者的常规护理中的新颖应用。试验结果可能为鼓励早期严重疾病对话和在临床环境中应用死亡率风险预测提供策略。
Clinicaltrials.gov 标识符:NCT03984773。